Low-value care: antipsychotic medication use among community-dwelling medicare beneficiaries with Alzheimer’s disease and related dementias and without severe mental illness

References

• Babitsch, B., Gohl, D., & von Lengerke, T. (2012). Re-revisiting Andersen’s Behavioral Model of health services use: A systematic review of studies from 1998–2011. GMS Psycho-Social-Medicine, 9, 1–15.
   PubMedGoogle Scholar
• Bierman, A. S., & Clark, J. P. (2007). Performance measurement and equity. BMJ (Clinical Research ed.), 334(7608), 1333–1334.
   PubMedGoogle Scholar
• Buterbaugh, W. M., Jamrose, T., Lazzara, J., Honaker, L., & Thomas, C. J. (2014). Review of antidepressants in the treatment of behavioral and psychiatric symptoms in dementia (BPSD). Mental Health Clinician, 4(4), 183–188.
   Google Scholar
• Campana, M., Bonin-Guillaume, S., Yagoubi, R., Berbis, J., & Franqui, C. (2016). Difficulties encountered by general practitioners during acute behavioral disturbances of their dementia patients. Geriatrie et Psychologie Neuropsychiatrie Du Vieillissement, 14(2), 167–174.
   PubMed Web of Science ®Google Scholar
• CCD Warehouse. (2018). Chronic Conditions Data Warehouse. Retrieved from https://www.ccwdata.org/web/guest/condition-categories
   Google Scholar
• Colla, C. H., Morden, N. E., Sequist, T. D., Schpero, W. L., & Rosenthal, M. B. (2015). Choosing wisely: prevalence and correlates of low-value health care services in the United States. Journal of General Internal Medicine, 30(2), 221–228.
   PubMed Web of Science ®Google Scholar
• Eppig, F. J., & Chulis, G. S. (1997). Matching MCBS (Medicare Current Beneficiary Survey) and Medicare data: The best of both worlds. Health Care Financing Review, 18(3), 211.
   PubMedGoogle Scholar
• Foebel, A., Ballokova, A., Wellens, N. I., Fialova, D., Milisen, K., Liperoti, R., & Hirdes, J. P. (2015). A retrospective, longitudinal study of factors associated with new antipsychotic medication use among recently admitted long-term care residents. BMC Geriatrics, 15(1), 128.
   PubMedGoogle Scholar
• Gelenberg, A. J., Freeman, M. P., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., … Fawcett, J. A. (2010). Practice guideline for the treatment of patients with major depressive disorder third edition. The American Journal of Psychiatry, 167(10), 1.
   PubMed Web of Science ®Google Scholar
• Huang, T., Tom, S., Harris, I., & Simoni-Wastila, L. (2016). Regional variation in pharmacological treatment initiation among older adults with serious mental illness. Value in Health, 19(3), A194.
   Web of Science ®Google Scholar
• Jeste, D. V., Blazer, D., Casey, D., Meeks, T., Salzman, C., Schneider, L., … Yaffe, K. (2008). ACNP White Paper: Update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology, 33(5), 957.
   PubMed Web of Science ®Google Scholar
• King, M., & Essick, C. (2013). The geography of antidepressant, antipsychotic, and stimulant utilization in the United States. Health & Place, 20, 32–38.
   PubMed Web of Science ®Google Scholar
• Kolanowski, A., Fick, D., Waller, J. L., & Ahern, F. (2006). Outcomes of antipsychotic drug use in community-dwelling elders with dementia. Archives of Psychiatric Nursing, 20(5), 217–225.
   PubMed Web of Science ®Google Scholar
• Liperoti, R., Pedone, C., & Corsonello, A. (2008). Antipsychotics for the treatment of behavioral and psychological symptoms of dementia (BPSD). Current Neuropharmacology, 6(2), 117–124.
   PubMed Web of Science ®Google Scholar
• Lövheim, H., Sandman, P.-O., Kallin, K., Karlsson, S., & Gustafson, Y. (2006). Relationship between antipsychotic drug use and behavioral and psychological symptoms of dementia in old people with cognitive impairment living in geriatric care. International Psychogeriatrics, 18(04), 713–726.
   PubMedGoogle Scholar
• Morley, J. E. (2012). Antipsychotics and dementia: A time for restraint? Journal of the American Medical Directors Association, 13(9), 761–763.
   PubMed Web of Science ®Google Scholar
• Neuhaus, J. M., & McCulloch, C. E. (2014). Covariate decomposition methods for longitudinal missing‐at‐random data and predictors associated with subject‐specific effects. Australian & New Zealand Journal of Statistics, 56(4), 331–345.
   PubMed Web of Science ®Google Scholar
• Olivieri-Mui, B. L., Devlin, J. W., Ochoa, A., Schenck, D., & Briesacher, B. (2018). Perceptions vs. evidence: Therapeutic substitutes for antipsychotics in patients with dementia in long-term care. Aging & Mental Health, 22(4), 544–549.
   PubMed Web of Science ®Google Scholar
• Poisal, J. A., Murray, L. A., Chulis, G. S., & Cooper, B. S. (1999). Prescription drug coverage and spending for Medicare beneficiaries. Health Care Financing Review, 20(3), 15.
   PubMedGoogle Scholar
• Rattinger, G. B., Burcu, M., Dutcher, S. K., Chhabra, P. T., Rosenberg, P. B., Simoni-Wastila, L., … Zuckerman, I. H. (2013). Pharmacotherapeutic management of dementia across settings of care. Journal of the American Geriatrics Society, 61(5), 723–733.
   PubMed Web of Science ®Google Scholar
• Rhee, Y., Csernansky, J. G., Emanuel, L. L., Chang, C., & Shega, J. W. (2011). Psychotropic medication burden and factors associated with antipsychotic use: An analysis of a population‐based sample of community‐dwelling older persons with dementia. Journal of the American Geriatrics Society, 59(11), 2100–2107.
   PubMed Web of Science ®Google Scholar
• Schneider, L. S., Dagerman, K. S., & Insel, P. (2005). Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. Jama, 294(15), 1934–1943.
   PubMed Web of Science ®Google Scholar
• Semla, T. P., Beizer, J., Brandt, N., Dombrowski, R., DuBeau, C. E., Eisenberg, W. (2015). Flanagan, N. American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 63(11), 2227–2246.
   PubMed Web of Science ®Google Scholar
• US Government Accountability Office. (2015). Antipsychotic drug use: HHS has initiatives to reduce use among older adults in nursing homes, but should expand efforts to other settings.
   Google Scholar
• Verkerk, E. W., Tanke, M. A. C., Kool, R. B., van Dulmen, S. A., & Westert, G. P. (2018). Limit, lean or listen? A typology of low-value care that gives direction in de-implementation. International Journal for Quality in Health Care, mzy100–mzy100. https://doi.org/10.1093/intqhc/mzy100
   Web of Science ®Google Scholar
• Wagner, A. K., Chan, K. A., Dashevsky, I., Raebel, M. A., Andrade, S. E., Lafata, J. E., … Platt, R. (2006). FDA drug prescribing warnings: Is the black box half empty or half full?. Pharmacoepidemiology and Drug Safety, 15(6), 369–386.
   PubMed Web of Science ®Google Scholar
• Wells, K., Sherbourne, C., Schoenbaum, M., Ettner, S., Duan, N., Miranda, J., … Rubenstein, L. (2004). Five-year impact of quality improvement for depression: Results of a group-level randomized controlled trial. Archives of General Psychiatry, 61(4), 378–386.
   PubMed Web of Science ®Google Scholar